Effects of atorvastatin (80 mg) therapy on quantity of epicardial adipose tissue in patients undergoing pulmonary vein isolation for atrial fibrillation

American Journal of Cardiology

Volumn 116, Issue 9, 2015, Pages 1443-1446

  Soucek, Filip ^a,b,c   Covassin, Naima ^a   Singh, Prachi ^a   Ruzek, Lukas ^a,b,c   Kara, Tomas ^a,b,c   Suleiman, Mahmoud ^a   Lerman, Amir ^a   Koestler, Celeste ^a   Friedman, Paul A ^a   Lopez Jimenez, Francisco ^a   Somers, Virend K ^a  

^a MAYO CLINIC   (United States)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^c MASARYK UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; HYPOCHOLESTEROLEMIC AGENT;

ADIPOSE TISSUE; ADULT; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE MARKER; EPICARDIAL ADIPOSE TISSUE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY VEIN ISOLATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; BLOOD; DIAGNOSTIC IMAGING; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; METABOLISM; PERICARDIUM; PREDICTIVE VALUE; PULMONARY VEIN; SENSITIVITY AND SPECIFICITY; SURGERY; X-RAY COMPUTED TOMOGRAPHY;

ADIPOSE TISSUE; ANTICHOLESTEREMIC AGENTS; ATORVASTATIN CALCIUM; ATRIAL FIBRILLATION; BIOMARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERICARDIUM; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULMONARY VEINS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84944355526     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.07.067     Document Type: Article

References (19)

1. G. Iacobellis, D. Corradi, and A.M. Sharma Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart Nat Clin Pract Cardiovasc Med 2 2005 536 543
2. H.S. Sacks, J.N. Fain, B. Holman, A. Chary, F. Parks, J. Karas, R. Optican, S.W. Bahouth, E. Garrett, R.Y. Wolf, R.A. Carter, T. Robbins, D. Wolford, and J. Samaha Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat J Clin Endocrinol Metab 94 2009 3611 3615
3. G. Iacobellis, A.E. Malavazos, and M.M. Corsi Epicardial fat: from the biomolecular aspects to the clinical practice Int J Biochem Cell Biol 43 2011 1651 1654
4. J.J. Brugts, T. Yetgin, S.E. Hoeks, A.M. Gotto, J. Shepherd, R.G. Westendorp, A.J. de Craen, R.H. Knopp, H. Nakamura, P. Ridker, R. van Domburg, and J.W. Deckers The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials BMJ 338 2009 b2376
5. C. Baigent, A. Keech, P.M. Kearney, L. Blackwell, G. Buck, C. Pollicino, A. Kirby, T. Sourjina, R. Peto, R. Collins, R. Simes Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
6. N. Alexopoulos, B.H. Melek, C.D. Arepalli, G.R. Hartlage, Z. Chen, S. Kim, A.E. Stillman, and P. Raggi Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: a substudy of the BELLES Trial (Beyond Endorsed Lipid Lowering with EBT Scanning) J Am Coll Cardiol 61 2013 1956 1961
7. M. Suleiman, C. Koestler, A. Lerman, F. Lopez-Jimenez, R. Herges, D. Hodge, D. Bradley, Y.M. Cha, P.A. Brady, T.M. Munger, S.J. Asirvatham, D.L. Packer, and P.A. Friedman Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: a double-blind, placebo-controlled, randomized trial Heart Rhythm 9 2012 172 178
8. V. Fuster, L.E. Rydén, D.S. Cannom, H.J. Crijns, A.B. Curtis, K.A. Ellenbogen, J.L. Halperin, J.Y. Le Heuzey, G.N. Kay, J.E. Lowe, S.B. Olsson, E.N. Prystowsky, J.L. Tamargo, S. Wann, S.C. Smith Jr., A.K. Jacobs, C.D. Adams, J.L. Anderson, E.M. Antman, J.L. Halperin, S.A. Hunt, R. Nishimura, J.P. Ornato, R.L. Page, B. Riegel, S.G. Priori, J.J. Blanc, A. Budaj, A.J. Camm, V. Dean, J.W. Deckers, C. Despres, K. Dickstein, J. Lekakis, K. McGregor, M. Metra, J. Morais, A. Osterspey, J.L. Tamargo, J.L. Zamorano American College of Cardiology/American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e257 e354
9. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, I. Savelieva, S. Ernst, I.C. Van Gelder, N. Al-Attar, G. Hindricks, B. Prendergast, H. Heidbuchel, O. Alfieri, A. Angelini, D. Atar, P. Colonna, R. De Caterina, J. De Sutter, A. Goette, B. Gorenek, M. Heldal, S.H. Hohloser, P. Kolh, J.Y. Le Heuzey, P. Ponikowski, and F.H. Rutten Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the national cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
11. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J. Shanewise, S. Solomon, K.T. Spencer, M. St John Sutton, W. Stewart American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography; European Society of Cardiology Recommendations for chamber quantification Eur J Echocardiogr 7 2006 79 108
12. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation Chest 137 2010 263 272
13. N. Alexopoulos, D.S. McLean, M. Janik, C.D. Arepalli, A.E. Stillman, and P. Raggi Epicardial adipose tissue and coronary artery plaque characteristics Atherosclerosis 210 2010 150 154
14. C.G. Mihos, A.M. Pineda, and O. Santana Cardiovascular effects of statins, beyond lipid-lowering properties Pharmacol Res 88 2014 12 19
15. E. Nishio, K. Tomiyama, H. Nakata, and Y. Watanabe 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor impairs cell differentiation in cultured adipogenic cells (3T3-L1) Eur J Pharmacol 301 1996 203 206
16. K. Tomiyama, E. Nishio, and Y. Watanabe Both wortmannin and simvastatin inhibit the adipogenesis in 3T3-L1 cells during the late phase of differentiation Jpn J Pharmacol 80 1999 375 378
17. T. Khan, M.P. Hamilton, D.I. Mundy, S.C. Chua, and P.E. Scherer Impact of simvastatin on adipose tissue: pleiotropic effects in vivo Endocrinology 150 2009 5262 5272
18. R. Krysiak, K. Labuzek, and B. Okopien Effect of atorvastatin and fenofibric acid on adipokine release from visceral and subcutaneous adipose tissue of patients with mixed dyslipidemia and normolipidemic subjects Pharmacol Rep 61 2009 1134 1145
19. G. Iacobellis, M.C. Ribaudo, F. Assael, E. Vecci, C. Tiberti, A. Zappaterreno, U. Di Mario, and F. Leonetti Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk J Clin Endocrinol Metab 88 2003 5163 5168